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Abstract
Pulmonary surfactant contains less than 1 wt% of the very non-polar surfactant protein C (SP-C). In most animal species
the major form of SP-C is a 35-residue peptide chain which contains two thioester-linked palmitoyl groups, giving a total
molecular mass of 4.2 kDa. Several minor variants of SP-C exist, formed from N-terminal truncation, lysine palmitoylation,
methionine oxidation and C-terminal esterification. The primary structure is evolutionarily conserved and SP-C appears to
be the only constituent which is unique to pulmonary surfactant, indicating important and specific functions. The three-
dimensional structure in an aqueous mixed organic solvent determined by NMR spectroscopy revealed one continuous 37 Aî
long K-helix encompassing residues 9^34 as the only regular structural element. The central 23 Aî of the helix contains
exclusively aliphatic residues with branched side-chains, mainly valines, and exposes an all-hydrophobic regular surface. The
size of the entire helix perfectly matches the thickness of a fluid dipalmitoylphosphatidylcholine membrane, and the all-
hydrophobic part of the helix matches the acyl-chain part of such a bilayer. This supports a transmembrane orientation of
SP-C in pulmonary surfactant bilayers. In a phospholipid monolayer, the SP-C helix is tilted, thereby maximizing the
interactions with the lipid acyl-chains also in this environment. The palmitoylcysteines of SP-C, which are located in the
flexibly disordered N-terminal octapeptide segment, appear to be important both for integrity of the K-helical structure and
for functional properties. Since the conformation of the N-terminal part in a phospholipid environment is not known, the
mechanisms whereby the SP-C thioester-linked palmitoyl chains affect structure and function remain to be
determined. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pulmonary surfactant is quantitatively strongly
dominated by phospholipids, but ever since the ¢rst
successful attempts to obtain surfactant material
pure enough for chemical characterization it has
been evident that proteins constitute up to approxi-
mately 10% of the weight [1]. The presence of truly
hydrophobic proteins in surfactant was, however,
not recognized until the late seventies, when proteins
soluble in ether/ethanol were found [2]. The strictly
hydrophobic surfactant proteins B and C (SP-B and
SP-C) have been separated mainly by gel ¢ltration on
Sephadex LH-60 in acidi¢ed aqueous organic sol-
vents [3]. Extensive analysis of these proteins, in par-
ticular SP-C, have yielded relatively detailed structur-
al information, while their functions in pulmonary
surfactant still are to a large extent unknown [4].
SP-C is di⁄cult to handle experimentally primarily
because of a pronounced hydrophobicity; it is ac-
tually one of the most non-polar naturally occurring
polypeptides known, and is furthermore structurally
unstable under certain conditions [5^7]. These exper-
imental obstacles in combination with the lack of a
quantitative assay for SP-C activity, and consequent
lack of possibilities to judge the amount of active
peptide, makes it essential to ascertain structural in-
tegrity before functional studies are undertaken. This
is probably most reliably achieved by circular dichro-
ism (CD) or Fourier transform infrared (FTIR) spec-
troscopy, whereby SP-C is expected to be 70^80%
helical in detergent micelles, chloroform/methanol
mixtures or short-chain alcohols. Recently, a high-
resolution reversed-phase high performance liquid
chromatography (HPLC) method for isolation and
analysis of SP-C, using mixtures of aqueous alcohols
as mobile phases, was published [8]. With this meth-
od, native helical SP-C can be distinguished from
aggregated, non-helical forms by di¡erent chromato-
graphic behaviors. HPLC thus o¡ers a complement
to spectroscopic techniques for the analysis of SP-C
gross secondary structure.
Transgenic mice that harbor SP-C/reporter gene
constructs show that SP-C is exclusively expressed
in the lung [9]. SP-C is the only of the identi¢ed
surfactant proteins which is pulmonary surfactant-
speci¢c, and is in fact the sole constituent that ap-
pears to be unique to pulmonary surfactant. It is,
furthermore, the only surfactant protein that lacks
known homologous proteins. SP-C is proteolytically
derived from an approximately ¢ve times larger pre-
cursor, where the non-SP-C parts share no similarity
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to the mature peptide in terms of amino acid se-
quence or hydrophobicity. This review will describe
the structure of SP-C in detail and discuss the struc-
tural features that appear important for functional
properties, and the ensuing implications for design
of synthetic analogs.
2. Covalent structure of SP-C
SP-C is a pronouncedly hydrophobic molecule be-
cause it contains s 70% non-polar residues, and be-
cause it carries covalently linked fatty acyl chains
[10]. SP-C isolated from pulmonary surfactant is
not one unique molecule, but is instead composed
of a mixture of isoforms, whereof one is likely to
be the quantitatively dominating in vivo. The num-
ber of known modi¢cations appears to increase in
parallel with increased analytical sensitivity, and it
is most likely that additional SP-C isoforms will be
found. Although the major form of SP-C is presum-
ably the biologically active molecule, characteriza-
tion of the minor isoforms is important since it gives
clues regarding the proteolytic formation of SP-C,
ageing of SP-C in a phospholipid environment, and
is also essential for understanding the relationships
between structure and activity of SP-C.
2.1. The main form of SP-C
The human, porcine and rabbit SP-C polypeptide
chain contains 35 amino acid residues (Fig. 1), while
canine and bovine SP-C are one residue shorter be-
cause of deletion of the very N-terminal residue. This
may, however, not be a true species di¡erence, but
the result of di¡erent extents of N-terminal trunca-
tion (see below). SP-C is posttranslationally modi¢ed
by addition of one (in canine and mink SP-C) or two
(all other species analyzed) palmitoyl groups via thio-
ester bonds to Cys-5 and Cys-6 (in canine and mink
SP-C Cys-6 is replaced by Phe). A stoichiometry
close to 1:1 between Cys residues and palmitoyl
groups has been found in SP-C isolated from normal
lungs, while increased amounts of non- and monopal-
mitoylated SP-C are found in human alveolar pro-
teinosis surfactant [11]. Alignment of the amino acid
sequences of SP-C from human, porcine, bovine, ca-
nine, rabbit, rat and mouse reveals four di¡erent
conserved regions [12]. First, the stretch covering po-
sitions 13^28, the ‘poly-valyl’ region, contains exclu-
sively aliphatic residues with branched side-chains,
mainly Val, in all species. Only a few conservative
residue exchanges are found. Leu-22, which is strictly
conserved, is situated in between two stretches with
seven and four consecutive L-branched residues. Sec-
ond, the C-terminal heptapeptide segment that fol-
lows directly after the poly-valyl region is also strictly
conserved. Third, the Lys-Arg dibasic pair at posi-
tions 11 and 12 is strictly conserved. Fourth, palmi-
toylated cysteines at positions 5 and 6 are found in
all species, except in dog and mink as stated above,
and are without exception surrounded by prolines at
positions 4 and 7. In fact, only the N-terminal dipep-
tide segment and positions 8^9 exhibit non-conserva-
tive residue exchanges.
2.2. Covalent isoforms of SP-C
Isoforms where one or both of the thioester-linked
palmitoyl chains are missing have been found [8,10^
Fig. 1. Covalent structure and modi¢cations of SP-C. The amino acid sequence of porcine SP-C is shown in one-letter code and the
known modi¢ed residues are identi¢ed with boxes. From left to right the boxes show N-terminal truncation, thioester-linked palmitoyl
groups of Cys-5 and Cys-6, palmitoyl chain amide-bound to Lys-11, sulfoxide of Met-33, and C-terminal methyl-ester. Selected parts
of the structures of only the modi¢ed forms are shown, except for the N-terminal processing, where both full-length (unmodi¢ed) pep-
tide and trunctated versions are identi¢ed.
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14] and likely re£ects the intrinsically labile nature of
the thioester bond. In addition, four modi¢cations
that involve breakage of peptide bonds or covalent
addition of di¡erent groups to the major SP-C mol-
ecule have been detected (Fig. 1). (1) N-Terminally
truncated forms starting at position 2 or 3 of the
major form were found during the determination of
the amino acid sequence. Together, the truncated
forms constitute 15^70% of all molecules. The rea-
son(s) for this phenomenon is unknown, but likely
explanations include low speci¢city of the enzyme
that cleaves the N-terminal part of SP-C from
proSP-C, and aminopeptidase activity taking place
after SP-C has been liberated, perhaps also during
the puri¢cation procedure. Artefactual origin, how-
ever, seems less likely because of constant occurrence
of the truncated forms and the fact that the peptide
isolation is performed from tissue solubilized in or-
ganic solvents, which largely inhibit proteolysis. It is
di⁄cult to envision any major functional e¡ects of
the truncations, since the di¡erences are compara-
tively minor and occur in a region where residue
exchanges are allowed judging from sequence align-
ments. (2) An isoform that contains a palmitoyl
group linked to the O-amino group of Lys-11 was
separated from the main form of porcine SP-C by
reversed-phase HPLC [8]. This form constitutes
about 4% of the main form and was suggested to
be formed by acyl transfer from surrounding phos-
pholipids in surfactant. Considering that Lys-11 is
strictly conserved, and that neutralization of the pos-
itive charges of SP-C has been shown to a¡ect func-
tion [15] it is likely that lysine palmitoylated peptides
exhibit impaired activity. (3) Met-33 is oxidized to
methionine sulfoxide in a signi¢cant fraction of iso-
lated SP-C, as detected by mass spectrometry [16],
and NMR spectroscopy [6]. The origin and e¡ects
of this is di⁄cult to judge, but as Met-33 is strictly
conserved, it may a¡ect functional properties. (4) C-
Terminally methyl-esteri¢ed SP-C has been observed
by mass spectrometry and reversed-phase HPLC
[8,16]. Esteri¢cation likely occurs in the acidic meth-
anol solution commonly used for Sephadex LH-60
chromatography [3]. Functional consequences cannot
be excluded since the ester formation involves a
change in overall peptide charge. In conclusion, it
can be noted that most of the potentially reactive
groups of SP-C have been found to carry covalent
modi¢cations, at least in fractions of the peptide
(Fig. 1).
Fig. 2. The SP-C K-helix. Polypeptide backbone fold of the hel-
ical part of SP-C encompassing residues 9^34. The N-terminal
end is located at the top. The amphiphilic nature of the helix is
highlighted. Basic residues (Lys, Arg) are colored blue, non-po-
lar residues (Val, Ile, Leu, Ala, Met) are yellow and remaining
residues are in green.
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3. Conformation of SP-C
3.1. Solution structure of SP-C
The conformation of SP-C in chloroform/metha-
nol/0.1 M HCl, 32:64:5 (by volume) has been deter-
mined by two-dimensional 1H-NMR methods [6].
The structure reveals one very regular K-helix with
nearly ideal helix geometry and which encompasses
positions 9^34. The N-terminal eight residues, in-
cluding the two palmitoylcysteines at positions 5
and 6 are £exibly disordered in this acidic aqueous
mixed organic solvent. SP-C presents a very regular
and non-polar surface formed by the poly-valyl part
of the helix. The M1 angles of residues 15^28 are
practically identical and non-polar side-chains con-
tribute approximately 80% of the solvent accessible
surface of SP-C. The SP-C helix can be regarded as
overall amphiphilic, where the Lys-Arg pair at posi-
tions 11 and 12 presents charged and polar side-
chains and the poly-valyl helix exposes an extended
and nearly uniform lipophilic surface (Fig. 2).
3.2. Implications for the structure of SP-C in vivo
What does the structure of SP-C in an aqueous
mixed organic solvent tell about the conformation
of SP-C in its physiological environment? With a
few exceptions, which mainly are caused either by
SP-C’s tendency to aggregate or structural e¡ects of
surrounding phospolipids (see below), the overall
helical contents of SP-C in di¡erent environments
and determined with several di¡erent techniques are
in reasonable agreement with the helical content de-
termined in solution by NMR [17]. By FTIR spec-
troscopy, it was shown earlier that SP-C is oriented
in a transmembrane way in dipalmitoylphosphatidyl-
choline (DPPC)/dipalmitoyl-phosphatidylglycerol
(DPPG) or DPPC/phosphatidylglycerol (PG) bi-
layers [18,19]. The size of the SP-C K-helix in organic
solvents strongly supports a transmembranous orien-
tation in phospholipid bilayers [20]. The length of the
helix encompassing residues 9^34 is 37 Aî and the
poly-valyl part measures 23 Aî . This is in very good
agreement with the thickness of a £uid DPPC bilayer
(37 Aî ) and its acyl-chain part (26 Aî ). In contrast to
the near-perfect ¢t between the SP-C helix and a
£uid DPPC bilayer, the helix appears less suited to
be incorporated into a gel-phase DPPC bilayer, the
hydrocarbon part of which measures 39 Aî [4]. A
phospholipid monolayer does not agree in thickness
with the SP-C helix and the helix is unlikely to bend
for reasons explained below, together favoring an
association of SP-C with phospholipid bilayers rather
than a monolayer [20]. However, it was recently
shown that SP-C situated in a DPPC monolayer
makes a 70‡ tilt relative to a normal to the mono-
layer plane [21]. In this way, optimal interactions
between the poly-valyl helix lipophilic surface and
the phospholipid acyl-chains can be accomplished
also in a monolayer. Creuwels et al. previously con-
cluded that the SP-C helix axis is di¡erently oriented
in a monolayer, depending on whether the palmitoyl
chains are present or not, where depalmitoylation
resulted in an orientation more parallel to the phos-
pholipid acyl chains [22]. The exact localization of
SP-C in pulmonary surfactant remains an open ques-
tion, and from the presently available data, it is pos-
sible that the peptide can be incorporated in both
phospholipid bilayers and monolayers.
In contrast to the situation with the helical part,
the disordered conformation of the SP-C N-terminal
eight residues in solution are not likely to be repre-
sentative for their structure in a phospholipid envi-
ronment. In phospholipids, the N-terminal octapep-
tide segment is presumably anchored close to the
phospholipid layer via the thioester-linked palmitoyl
moieties. Firm conclusions about the conformation
of the N-terminal part of SP-C in a phospholipid
environment have to await further experimental
data.
4. Stability of the SP-C structure
Apart from being an unusually lipophilic peptide
which appears to be optimally suited for interactions
with pulmonary surfactant phospholipids, the stabil-
ity of the SP-C helix exhibits several interesting fea-
tures. Some of these may have implications not only
for SP-C function in pulmonary surfactant, but also
for understanding protein-unfolding mechanisms.
4.1. Dynamics of SP-C
The K-helix of SP-C is very rigid. FTIR spectro-
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scopy showed that 60^70% of the amide protons of
dried SP-C ¢lms or SP-C in DPPC/DPPG vesicles
did not exchange with 2H2O [18,19], and NMR spec-
troscopy of SP-C in an aqueous organic solvent re-
vealed that the amide protons from positions 10 to
32 exchange slowly [6]. This indicates a stable hydro-
gen-bonded structure that rarely opens up and ex-
poses the polypeptide backbone to the solvent. Fur-
thermore, SP-C in dodecylphosphocholine (DPC)
micelles is stable towards heat denaturation, exhibit-
ing approximately 45% helical structure at 90‡C [7].
Molecular dynamics (MD) simulations of K-helical
SP-C in chloroform, methanol or water at 300 and
500 K [23] showed that, at 300 K in methanol or
water, the conformation is virtually unchanged dur-
ing 1 ns simulation. In chloroform, at 300 K the K-
helical structure remains largely intact in the poly-
valyl region, but the C-terminal part starts to unfold.
The central part of the SP-C poly-valyl helix is even
stable for 900 ps at 500 K in water, while in chloro-
form the helix then unfolds within 180 ps [23] and
(H. Kovacs, W. van Gunsteren, J. Johansson and A.
Mark, to be published). The stability of SP-C ob-
served by MD simulations contrasts to results from
MD simulations of similarly sized peptides and larg-
er proteins. The higher stability of the SP-C helix in
the polar solvents methanol and water compared to
the non-polar solvent chloroform is striking. It is
probably caused in part by hydrophobic e¡ects
where the exposure of buried parts of the valyl
side-chains is more unfavorable in methanol and
water than in chloroform. Maybe the rigidifying ef-
fect of a more polar environment is a means to pro-
tect SP-C from rapid unfolding upon inadvertent re-
moval from the non-polar phospholipid membrane
interior.
The experiments with SP-C in DPC micelles [7]
showing high thermal stability and partial reversibil-
ity of thermal unfolding imply that the K-helix is
thermodynamically stable in this phospholipid micel-
lar environment. This is apparently not the case in
chloroform/methanol/0.1 M HCl. In spite of the ri-
gidity of the SP-C helix, over time it irreversibly ag-
gregates in the aqueous organic solvent mixture [6].
Presumably, this involves transformation of the helix
into an extended structure and concomitant aggrega-
tion of non-helical peptides (Fig. 3). This means that
the SP-C helix is metastable in solution, but the
structural conversion occurs in a slow manner be-
cause of a high kinetic barrier [24]. This metastability
has implications for the folding of SP-C in vivo.
E⁄cient folding of SP-C probably requires the pre-
cursor and possibly additional factors in order to
prevent aggregation and to make the formation of
the SP-C poly-valyl helix energetically favorable. The
KCL transition of SP-C resembles structural transi-
tions that occur in amyloid-forming proteins, like
e.g., the Alzheimer L peptide and the prion protein
[25]. It is tempting to speculate that protein meta-
stability, irrespective of underlying cause, is a com-
mon phenomenon in amyloid formation. Interest-
ingly, the Alzheimer L peptide emanates from a
transmembane region of its precursor protein.
In line with the observed metastability of SP-C, a
synthetic peptide with identical amino acid sequence
as the native peptide, but lacking the palmitoyl
chains, does not fold into a helical conformation to
any signi¢cant extent under various experimental
conditions, and has a pronounced tendency to form
insoluble aggregates [7]. In other words, starting
from an extended conformation aggregation is fa-
Fig. 3. Structural transitions of SP-C. Schematic presentation of
possible structural transitions of SP-C in solution, deduced
from analysis of the native peptide and synthetic analogs. First,
native SP-C (left) where residues 9^34 are K-helical (symbolized
by the barrel) and the remaining residues are £exibly disordered
can probably over time convert into an extended non-helical
conformation (middle), which eventually can form an aggregate
of several SP-C molecules in extended conformation (right).
Second, organic chemical synthesis of SP-C results in peptides
with extended structure (middle) which are more likely to ag-
gregate than to form helical peptides.
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vored over formation of helical structure (Fig. 3).
Furthermore, non-helical SP-C showed very low sur-
factant activity in vitro and the metastability of hel-
ical SP-C therefore has implications for the design of
analogs for formulation of a synthetic surfactant, see
further below. Interestingly, synthetic poly-valyl SP-
C analogs and recombinant SP-C produced in Es-
chericha coli have been found to be active as constit-
uents of arti¢cial surfactant preparations both in vi-
tro and in vivo, but the conformations of these
peptides were not reported [26,27].
4.2. Structural e¡ects of the thioester-linked palmitoyl
chains
Chemical depalmitoylation of SP-C causes approx-
imately 20% reduction of the K-helical content. The
extent of reduction in helical structure appears to be
independent of the environment used for analysis
[7,19,28]. The molecular basis behind this unfolding
remains to be resolved. One possible explanation is
that one or both of the palmitoyl groups serve as N-
capping residues, i.e. they form hydrogen bonds with
amide protons of the ¢rst helical turn, which other-
wise would remain unprotected. This is supported by
the fact that Leu-10 in the ¢rst helical turn is pro-
tected from amide proton exchange [6] and [24]. Al-
ternatively, the reduction of helical content is a con-
sequence of general destabilization of the helix and
conversion of a fraction of peptides into a non-heli-
cal conformation. This seems less likely for several
reasons. The MD simulations, which were performed
using non-palmitoylated SP-C for practical reasons,
revealed a very high stability of the poly-valyl helix.
Furthermore, aggregation of SP-C, at least the pal-
mitoylated peptide, is a comparatively slow process
and results in insoluble material that is expected to
be removed to a large extent during peptide puri¢ca-
tion before structural analysis. Depalmitoylated
SP-C is di⁄cult to isolate in large enough quantities
for high-resolution structural studies by NMR, and
determination of any conformational transitions tak-
ing place upon depalmitoylation will therefore re-
quire the use of more sensitive techniques. Experi-
mental data on the structural e¡ects of thioester-
linked palmitoyl chains in other systems are avail-
able, e.g. [29], but often show complex e¡ects which
are di⁄cult to abstract general principles from. In
the case of SP-C, one practical problem is that
most of the data have so far been derived using
chemically depalmitoylated peptide and inadvertant
e¡ects from the depalmitoylation procedure as such
cannot be ruled out. However, stoichiometric dipal-
mitoylation of a synthetic peptide corresponding to
SP-C positions 1^17 (SP-C(1^17)) causes a coil to
helix transition, as observed by CD spectroscopy of
the peptide in DPC micelles (E. Salakdeh-Youse¢, J.
Johansson and R. Stro«mberg, to be published). This
supports a true role of the palmitoyl chains in stabi-
lizing helical SP-C, but may also be an e¡ect of
stronger association of the palmitoylated peptide
with the DPC micelles and concomitant structural
changes. The detailed role of the thioester-linked pal-
mitoyl groups for structure and function of SP-C
stands out as an important topic for further studies.
Finally, also non-palmitoylated dimeric forms of SP-
C with almost entirely L-sheet or helical conforma-
tions have been puri¢ed from natural sources [13,14].
The L-sheet conformation observed is probably the
end-result of unfolding and aggregation (Fig. 3).
4.3. E¡ects of surrounding phospholipids
The K-helical content of both palmitoylated and
depalmitoylated SP-C is higher in phospholipid bi-
layers than in chloroform/methanol solution [19].
The helical contents of porcine SP-C determined by
FTIR and NMR in chloroform/methanol are almost
identical, 76 and 74%, respectively [6,19], and corre-
spond to the stable helix covering positions 9^34.
Consequently, the 92% helical content of SP-C in
DPPC/PG observed by FTIR [19] must indicate
that about ¢ve of the eight N-terminal residues be-
come helical in a phospholipid environment. Possi-
bly, in a phospholipid membrane the hydrocarbon
chains of the palmitoylcysteines will be located inside
the lipid bilayer, which in turn will locate the
N-terminal octapeptide segment close to the phos-
pholipids. This is in line with the ¢nding that in
DPPC/porcine SP-C mixtures, the positive charges
of the peptide, which are all located in the N-termi-
nal part (Fig. 1), are located near the bilayer surface
[30]. A tentative conformation of palmitoylated SP-C
in a lipid bilayer includes the transmembrane helix
spanning residues 9^34, a bend around residues Pro-
7 and Val-8 and about one and a half helical turns in
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the N-terminal six residues, see [4] for details. Again
it should be pointed out that this hypothesis lacks
experimental support, apart from the observations
mentioned above. Like for the e¡ects of the thioest-
er-linked palmitoyl groups, more experimental data
on the structure of SP-C in phospholipids are
needed.
The NMR-derived secondary structure of SP-C(1^
17) in DPC micelles [20] reveals a helical structure
covering Lys-11 to Val-17. In other words, the helix
in this shortened non-palmitoylated peptide begins
close to the N-terminal end of the K-helix (Asn-9)
of full-length palmitoylated SP-C in organic solvents.
This may mean that lost palmitoyl/peptide interac-
tions after depalmitoylation are, in a phospholipid
environment, replaced by phospholipid/peptide inter-
actions, resulting in refolding into a helical structure
similar to that of the palmitoylated peptide in solu-
tion. This is supported by the fact that the helical
content of depalmitoylated SP-C in phospholipid bi-
layers and of palmitoylated SP-C in chloroform/
methanol are very similar, 77 and 74^76%, respec-
tively [6,19].
5. SP-C in pulmonary surfactant
From the structural data on SP-C, some conclu-
sions about its function and fate in pulmonary sur-
factant can be made. However, the certainty of such
conclusions is relatively low and much remains to be
learned about the molecular functions of SP-C.
5.1. SP-C/lipid interactions
The SP-C helix is much shorter than the thickness
of gel phase phospholipid bilayers, and mismatches
between peptide length and bilayer thickness pro-
mote phase separations of peptides and lipids, see
[4]. In line with this, SP-C undergoes aggregation
in gel phase DPPC/PG bilayers, but is monomeric
in the £uid phase [31]. Furthermore, SP-C interacts
preferentially with £uid phospholipids with palmitoyl
fatty acyl chains, but is excluded from the corre-
sponding gel-phase bilayers [32,33]. This is compat-
ible with a scenario where aggregated SP-C peptides
disrupt lipid packing in gel-phase lipids, while in £u-
id phase bilayers SP-C is perfectly accommodated
[20]. In a DPPC monolayer SP-C is signi¢cantly
tilted away from a normal to the interface and there-
by presents a lipophilic surface to the phospholipids,
which allows high conformational order in the lipid
acyl-chains [21]. It was suggested that in a mono-
layer, SP-C may act as a ‘hydrophobic lever’ that
anchors and spreads a maximum number of phos-
pholipid molecules [21].
Studies of transmembrane model peptides raise the
intriguing possibility that the rigidity of the SP-C
helix may be functionally important [4]. This was
concluded from the fact that a synthetic transmem-
brane peptide consisting of a Leu-Ala dipeptide re-
peat can adjust to the increase in bilayer thickness
caused by a transition from £uid to gel phase lipids,
presumably via a transition from K-helical to a
310-helical structure [34]. In contrast, an analogous
peptide with a poly-Leu transmembrane part did not
exhibit conformational £exibility. The outstanding
rigidity of the SP-C K-helix also in a non-polar en-
vironment [23] presumably precludes any transition
to a 310-helix. The poly-valyl transmembrane K-helix
of SP-C is an unusual structural feature and it is
possible that it has evolved because of a pronounced
resistance to changes in the thickness of a surround-
ing lipid bilayer.
5.2. E¡ects of thioester-linked palmitoyl groups
Reduced adsorption and respreading of phospho-
lipids to an air/water interface, reduced mechanical
stability of the interfacial ¢lm, and inferior surface
tension lowering properties were observed both with
phospholipids puri¢ed from lungs and synthetic
phospholipids combined with SP-C polypeptide
where the palmitoyl groups had been chemically re-
moved [28,35]. This clearly indicates that palmitoyl-
ation is essential for optimal surface activity of
SP-C. SP-C, like several other palmitoylated pro-
teins, contains a non-polar transmembrane part
and remains membrane-associated also in the ab-
sence of the fatty acyl chains. The central function
of protein fatty acylation is therefore likely not to
simply associate proteins to lipid membranes. No
common function for protein fatty acylation is
known and proposed functions include regulation
of protein^protein interactions, membrane anchoring
of otherwise mobile peptide segments, and modula-
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tion of protein stability. Dynamic palmitoylation/de-
palmitoylation cycles, made possible by the intrinsic
lability of the thioester bond, is a central feature of
several hypotheses about functional signi¢cance of
protein palmitoylation. No evidence for the existence
of a signi¢cant fraction of non- or monopalmitoyl-
ated SP-C in normal pulmonary surfactant has been
obtained.
5.3. Anchoring of SP-C in phospholipids
In the case of SP-C, it can be speculated that the
palmitoyl groups are important because they anchor
the N-terminal part in the bilayer and/or because
they stabilize the conformation of the N-terminal
octapeptide segment. The N-terminal part of SP-C
harbors both the palmitoylcysteines and the two evo-
lutionarily conserved basic residues at positions 11
and 12 (Fig. 1). The palmitoyl groups are probably
anchored inside the phospholipids and the basic res-
idues likely interact with negative charges on the
phospholipid headgroups. Such interactions may se-
lectively restrict lateral movements of the N-terminal
end of SP-C in a bilayer, since the C-terminal end
contains only residues with small or non-polar side-
chains which are unable to anchor the peptide in the
bilayer. MD simulations of a 32-residue poly-Ala
helical peptide in a dimyristoylphosphatidylcholine
bilayer showed that the helix axis tilted signi¢cantly
from its initial orientation parallel with the lipid acyl-
chains [36]. It can thus be inferred that non-anchored
ends of single transmembrane helices can move sig-
ni¢cantly in a phospholipid bilayer. It has been pro-
posed that the combination of the rigid poly-valyl K-
helix of SP-C and a ‘mobility gradient’ are important
for the function of SP-C in surfactant phospholipids,
possibly by facilitating phospholipid spreading via
disruption of intermolecular acyl-chain packing
[20]. The uneven distribution of membrane-anchor-
ing residues and the di¡erential mobility may like-
wise be important for a function of SP-C in a phos-
pholipid monolayer.
5.4. Signi¢cance of Lys palmitoylation
About 4% of SP-C puri¢ed from lung tissue carry
a palmitoyl group linked to Lys-11. This is possibly
the result of non-enzymatic acyl-transfer from near-
by phospholipids to the nucleophilic O-amino group
of the lysine side-chain [8]. This modi¢cation could
therefore re£ect the SP-C natural environment, and
may be an e¡ect of ‘ageing’, analogous to covalent
modi¢cation of blood proteins by glucose.
6. Lessons from synthetic analogs of SP-C
Much of the structural characterization of SP-C
has been fueled by the fact SP-C appears to be an
essential component of surfactant preparations used
for replacement therapy of respiratory distress syn-
drome (RDS) in premature infants. It may also be
possible to treat other diseases with exogenous sur-
factants. Today, commercially available peptide-con-
taining surfactant preparations are obtained by ex-
tractions from animal lungs. Such procedures are
relatively demanding, the amounts obtained are lim-
ited, and propagation of infectious material cannot
be excluded. These circumstances contribute to the
need for a pharmacologically active synthetic surfac-
tant. Since the structure of SP-C is now known to a
signi¢cant extent, it appears realistic to design func-
tionally active synthetic SP-C analogs. However, the
unusual structure of SP-C has made this more di⁄-
cult than initially anticipated.
6.1. The poly-valyl K-helix
Synthetic SP-C does not form the same structure
as the one exhibited by native peptide puri¢ed from
lungs [7]. The poly-valyl peptide chain does not form
a helix to any signi¢cant degree under the conditions
commonly used for organic peptide synthesis. This is
not surprising considering the metastability of helical
SP-C in solvents similar to those used for peptide
synthesis and isolation [24] (Fig. 3). Denatured SP-
C or synthetic peptides in L-sheet like conformations
exhibit inferior surface activity compared to full-
length helical SP-C [7], making it necessary to ¢nd
ways to obtain synthetic helical SP-C analogs. Pos-
sibly, addition of phospholipids during in vitro pep-
tide folding could increase the yield of helical SP-C,
since the native helical peptide is stable in phospho-
lipids. Likewise, the addition of the precursor mole-
cule and/or other factors present during in vivo fold-
ing could favor formation of helical SP-C. This is,
BBADIS 61769 30-10-98 Cyaan Magenta Geel Zwart
J. Johansson / Biochimica et Biophysica Acta 1408 (1998) 161^172 169
however, probably laborious and technically de-
manding, and has not yet been reported to be practi-
cally e⁄cient. Instead alternative routes which cir-
cumvent the problems of folding a poly-valyl
sequence into a helix have been explored. In the ini-
tial experiments, the poly-valyl part of SP-C was re-
placed with the amino acid sequence of a transmem-
brane helix of bacteriorhodopsin. This produced a
helical peptide that closely resembled native SP-C
in terms of in vitro spreading properties [7]. Replace-
ment of the poly-valyl part of SP-C with a poly-
leucyl stretch produces an analog which nearly quan-
titatively forms a helix, also after acid-induced dena-
turation, induces spreading of phospholipids as e⁄-
cient as native SP-C and increases dynamic lung
compliance in premature rabbit fetuses with about
30% [37]. Also poly-leucyl or poly-norleucine
stretches linked to the heptapeptide segment covering
SP-C positions 6^12 give analogs which signi¢cantly
improve surface spreading at an air/water interface
and dynamic surface activity [38]. The present con-
clusion is that physiologically active SP-C analogs
can be obtained by replacing the poly-valyl part
with a peptide sequence that forms an non-polar
transmembrane helix in a phospholipid bilayer, but
the activity so far obtained with SP-C-based prepa-
rations appears to be inferior to those of natural-
derived surfactants.
6.2. Structure^activity relationships
Apart from the straightforward aim to obtain a
synthetic surfactant for treatment of RDS, design
and analysis of SP-C analogs can also yield informa-
tion about the molecular features that are important
for SP-C activity. This requires that the secondary
structure and orientation in phospholipid membranes
of the peptides in question are characterized along
with the functional parameters. For example, analy-
sis of truncated SP-C analogs have shown that a
helix which spans an entire phospholipid membrane
is needed for activity in vitro [39], and single trans-
membrane peptides, but not single amphipathic pep-
tides which are oriented parallel to the bilayer sur-
face, are e⁄cient in spreading phospholipids at an
air/water interface [37]. Finally, analysis of structure
and orientation of KL4, a synthetic peptide designed
as an SP-B analog [40], have given the surprising and
provocative result that it may be more appropriate to
consider it as an SP-C analog [41]. Such knowledge is
not only important for understanding basic struc-
ture^activity relationships pertinent to the native hy-
drophobic surfactant proteins, but may also help to
delineate which components are essential for formu-
lation of a synthetic surfactant.
7. Conclusions and future perspectives
SP-C exhibits several unusual structural features.
Its covalent structure has an extremely high content
of branched aliphatic side-chains and several cova-
lent posttranslational modi¢cations. The SP-C helical
conformation exhibits an extended lipophilic surface
with positive charges located at one end. SP-C is
short-term very stable, but forms aggregates of
non-helical peptides upon incubation in aqueous or-
ganic solvents, reminiscent of the supposed behavior
of amyloid-forming proteins. The metastability of
SP-C in solution is intriguing and it is speculated
that further studies of this phenomenon may gener-
ate data also of relevance to protein folding. Our
knowledge of the SP-C structure is still incomplete,
the major shortcomings being the lack of detailed
data on the structure of SP-C in a phospholipid
membrane and the structural e¡ects of the palmitoyl
chains. Evidence is accumulating that the SP-C pal-
mitoylcysteines are functionally important. This is
also expected from structural studies which indicate
destabilization of the helical structure upon depalmi-
toylation. SP-C analogs evaluated so far have been
non-palmitoylated since an e⁄cient method for syn-
thesis of stoichiometrically palmitoylated SP-C ana-
logs have not been available. However, such a meth-
od is under development and will hopefully make it
possible to evaluate in further detail the importance
of the palmitoylcysteines for structure and function
of SP-C.
Although not complete, the current knowledge
about the SP-C structure has made the rational de-
sign of peptide analogs for formulation of a synthetic
surfactant possible. Analysis of such analogs have
given insights about the structure^activity relation-
ships of SP-C and, furthermore, identi¢ed promising
candidates for formulation of a synthetic surfactant
for treatment of RDS. Continued design and analysis
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of SP-C (and SP-B) analogs will probably shed fur-
ther light on the structure^activity relationships of
these proteins, and ultimately result in formulation
of a pharmacologically active synthetic surfactant
preparation.
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